brentuximab,nivolumab
seagen,bms
['lymphoma', 'nivo', 'brentuximab', ' vedo', 'hodgkin', 'nivolumab']
 news from #asco23 patients w/advanced #hodgkinlymphoma had a higher pfs at 12 months when treated w/ #nivolumab &amp; avd chemotherapy than those w/ #brentuximab vedotin after one year of treatment. #meded 
COR2ED bringing you Independent Medical Education developed 
by LYMPHOMA & MYELOMA CONNECT, international experts in hematology and oncology